Home
News
Screeners
Insights
Decipher Labs
5.
89
+0.20
(+3.51%)
Market Cap
₹6.00 Cr
PE Ratio
-1.88
Industry
Healthcare
Buy
Sell
Company Performance:
1D
+3.51%
1M
+5.18%
6M
-18.76%
1Y
-41.10%
5Y
-82.02%
View Company Insights
Latest news about Decipher Labs
Decipher Labs passes all five resolutions at 40th annual general meeting
Sep 30, 2026
All five resolutions passed with requisite majority at the 40th AGM. Promoters holding 13.2% stake cast zero votes on all agenda items. Public shareholders voted 272,711 in favour, representing 3.11% turnout. Material related party transactions with Saya Healthcare approved.
Decipher Labs sets book closure for AGM from September 24 to 30
Sep 08, 2026
Decipher Labs narrows FY26 net loss to ₹24.68 crore
May 30, 2026
Decipher Labs Limited Submits Quarterly Compliance Certificate to BSE for Q4 FY26
Apr 17, 2026
Decipher Labs Limited Announces Q3FY26 Financial Results Under Regulation 33
Feb 12, 2026
More news about Decipher Labs
12
Feb 26
Decipher Labs Limited Shareholders Approve Director Appointment at Extraordinary General Meeting
Decipher Labs Limited conducted its Extraordinary General Meeting on February 12, 2026, where shareholders unanimously approved the appointment of Mr. Dalavath Amar Singh as Director and Whole-Time Director. The resolution received 237,806 votes in favor with zero opposition, representing 100% approval from the 72 voting shareholders. The e-voting process was conducted between February 9-11, 2026, with M/s. S.S. Reddy & Associates serving as scrutinizer to ensure regulatory compliance.
14
Nov 25
Decipher Labs Reports Quarterly Loss and Appoints New Executive Director
Decipher Labs Limited reported a consolidated loss before tax of Rs. 340.34 lakhs for the half-year ended September 30, 2025. Total revenue stood at Rs. 726.91 lakhs, with the Consultancy Services segment contributing Rs. 656.24 lakhs. The company appointed Mr. Dalavath Amar Singh as an Additional Director in the Executive category for two years, subject to shareholder approval, with an annual remuneration of Rs. 6 lakhs. As of September 30, 2025, the company's total assets and liabilities were Rs. 2,376.02 lakhs, with an equity share capital of Rs. 1,010.00 lakhs.
20
Sept 25
Decipher Labs Secures Partial Relief from SAT Against SEBI Order
Securities Appellate Tribunal (SAT) has granted partial relief to Decipher Labs Ltd against a SEBI order. SAT stayed restrictions on the company's securities dealings and allowed directors to sell shares. Coercive action for recovery of disgorgement and penalties is suspended, conditional on directors depositing 50% of the penalty within four weeks. The original SEBI order involved alleged violations of PFUTP, PIT, and LODR regulations. Decipher Labs stated the SAT order won't impact its financial or operational activities.
05
Sept 25
Decipher Labs Announces Key Appointments and Sets AGM Date
Decipher Labs Limited has approved several appointments following a Board meeting. M/s. Aakanksha Dubey & Co. has been appointed as Secretarial Auditors for a five-year term. Mr. Sushant Mohan Lal is the new Internal Auditor for 2025-26. Mrs. Lakshmi Vijaya Nimmala has been re-appointed as an Independent Director for five years. The company's AGM is scheduled for September 30, 2025, at 11:00 a.m. via video conference. M/s. S.S. Reddy & Associates will serve as the scrutinizer for e-voting during the AGM.
Decipher Labs
5.
89
+
0.
20
(+
3.
51
%)
1 Year Returns:
-41.10%
Industry Peers
Sun Pharmaceutical
1,760.00
(+
0.
01
%)
Divis Laboratories
9,340.00
(-
0.
22
%)
Torrent Pharmaceuticals
4,656.90
(+
0.
86
%)
Zydus Life Science
1,117.50
(+
0.
49
%)
Laurus Labs
2,036.60
(+
1.
94
%)
Cipla
1,301.00
(-
0.
44
%)
Dr Reddys Laboratories
1,197.00
(+
1.
44
%)
Mankind Pharma
2,368.50
(-
0.
48
%)
Aurobindo Pharma
1,693.00
(+
2.
92
%)
Lupin
1,956.50
(+
1.
01
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO
Cyclical Trend
Events Calendar